NCT06592963 Unfolding Severe and Enduring Eating Disorders (U-SEED)
| NCT ID | NCT06592963 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uppsala University Hospital |
| Condition | Eating Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-06-01 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aim of this study is to identify biological and psychological characteristics as risk factors in individuals with severe and enduring eating disorders (SEED). Specifically, the investigators aim to: 1. in a cohort of well-diagnosed eating disorder patients from 2005 followed up in National health registers, explore risk factors at baseline (recorded 2005-2007) for development of later SEED (the registry based cohort). 2. replicate the findings in a new sample of 50 adults with ongoing SEED. Participants will be assessed diagnostically and physically, and asked to fill out questionnaires and leave blood samples (the ongoing SEED sample compared with the register based cohort). 3. in a sample of 50 adults with SEED, explore demographic, biological, clinical, and psychological factors and examine the relation between these factors and symptom severity and functional impairment (the ongoing SEED sample). 4. explore participants perspectives on their symptoms and received care (the ongoing SEED sample).
Eligibility Criteria
For aim 1 (register based cohort): Incl. criteria: Attended care for eating disorders at Uppsala University Hospital between 2005 and 2007 and accepted to be included in a local quality register. Excl. criteria: None For aim 2 (ongoing SEED sample and register based cohort) Incl. criteria: * For ongoing SEED sample: Minimum age of 18, impairing eating disorder symptoms for at least seven years, and having at least one evidence-based treatment without remission or resulting in relapse. * For register based cohort, see above. Excl. criteria: * For ongoing SEED sample: Eating disorders symptoms in need of emergency care, high risk for suicide, and an inability to respond to the questionnaires due to lack of knowledge in Swedish. For aim 3 and 4 (the ongoing SEED sample). See above.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06592963 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06592963 currently recruiting?
Yes, NCT06592963 is actively recruiting participants. Contact the research team at martina.isaksson@uu.se for enrollment information.
Where is the NCT06592963 trial being conducted?
This trial is being conducted at Uppsala, Sweden.
Who is sponsoring the NCT06592963 clinical trial?
NCT06592963 is sponsored by Uppsala University Hospital. The trial plans to enroll 50 participants.